🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Healthstream executive sells $84,090 in company stock

Published 08/09/2024, 04:39 PM
HSTM
-

Senior Vice President of HealthStream Inc. (NASDAQ:HSTM), Kevin P. O'Hara, has recently sold shares of the company's common stock, according to the latest filings with the Securities and Exchange Commission. The transaction, which took place on August 7, 2024, involved the sale of 3,000 shares at a weighted average price of $28.03 per share, resulting in a total sale value of $84,090.

The sale was executed in multiple trades, and the price reported represents the weighted average sales price for the transactions. In the disclosure, Kevin P. O'Hara has committed to providing full information regarding the number of shares sold and the prices at which the sales were effected upon request by the SEC staff, the issuer, or a security holder of the issuer.

Following the sale, O'Hara's remaining direct ownership in HealthStream stands at 9,527 shares of common stock. This move by a senior executive is likely to be of interest to current and potential investors, as insider transactions can provide insights into a company's financial health and future prospects.

HealthStream Inc., headquartered in Nashville, Tennessee, specializes in computer programming, data processing, and other related services. The company's shares are publicly traded on the NASDAQ stock exchange under the ticker symbol HSTM.

In other recent news, HealthStream has demonstrated resilience amidst challenges, posting an increase in revenues, operating income, and net income for the second quarter of 2024. The revenue growth, which reached $71.6 million, was largely driven by subscription products, contributing 96% to total revenues. Despite facing hurdles such as the bankruptcy of a strategic account and a timing anomaly at a large customer, the company managed to expand its customer base in its ShiftWizard scheduling and CredentialStream credentialing solutions.

Canaccord Genuity maintained a 'Hold' rating on HealthStream, while raising the price target from $27 to $28, following the company's steady performance in the recent quarter. The firm acknowledged the company's challenges, including a $0.5 million revenue challenge due to a utilization anomaly and a $1.0 million operating income shortfall due to the bankruptcy of Steward Health. Despite these setbacks, HealthStream reaffirmed its full-year revenue and adjusted EBITDA guidance.

In addition to these developments, HealthStream reported the successful implementation of a 3.5% annual pricing increase with a west coast client, potentially supporting more substantial revenue growth over the coming years. The company's e-commerce channels also contributed $0.8 million to the quarter's revenue. Furthermore, HealthStream's SaaS scheduling solution, ShiftWizard, added eight new customers in the quarter, growing its revenue by 34%.

InvestingPro Insights

In light of the recent insider sale at HealthStream Inc. (NASDAQ:HSTM), investors may find additional context in the company's financial metrics and market performance. According to InvestingPro data, HealthStream currently holds a market capitalization of approximately $849.6 million. The company's Price/Earnings (P/E) ratio stands at 47.61, indicating a higher valuation compared to the market average. This is further reflected in the adjusted P/E ratio for the last twelve months as of Q2 2024, which is 48.59.

Despite the insider sale, HealthStream has a robust gross profit margin of 66.36% for the same period, demonstrating the company's ability to maintain profitability in its operations. Additionally, the company's revenue growth was 4.11% over the last twelve months as of Q2 2024, showing a steady increase in its top-line earnings.

InvestingPro Tips highlight that HealthStream has a perfect Piotroski Score of 9, suggesting a strong financial position. Furthermore, management's aggressive share buyback strategy could signal confidence in the company's value proposition. On the flip side, two analysts have revised their earnings expectations downwards for the upcoming period, which investors may want to consider in their analysis.

For those interested in a deeper dive into HealthStream's financials and market outlook, InvestingPro offers additional insights. There are currently 11 more InvestingPro Tips available for HSTM, which can be accessed for a comprehensive understanding of the company's financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.